Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| The Novo Nordisk Foundation Center for Basic Metabolic Research | OTHER |
| University of Copenhagen | OTHER |
| Steno Diabetes Center Greenland | OTHER |
Not provided
Not provided
Not provided
Not provided
Around 10% has type 2 diabetes in Greenland, despite being a practically unknown disease only six decades ago. The drastic increase is of great concern, especially considering the transition that have occurred during the same decades going from a fisher-hunter lifestyle towards a more western lifestyle. Today, traditional marine foods are still increasingly being replaced by imported foods high in refined sugar (sucrose) and starch. Furthermore, recent studies discovered that the Greenlandic population harbors a different genetic architecture behind type 2 diabetes. Hence, obtaining more knowledge on interactions between lifestyle, genetics, and metabolism is therefore crucial in order to ameliorate the growing curve, or maybe even turn it around.
Sucrose intolerance is in general rare; however, it is a common condition in Greenland and other Inuit populations. Here it is caused by a genetic variant in the sucrase-isomaltase (SI) gene, resulting in complete loss of enzyme function and hence an inability to digest sucrose and some of the glycosidic bonds in starch, both carbohydrates that are not part of the traditional Inuit diet. A recent, unpublished study found the variant to be associated with lower BMI, body fat percentage, bodyweight, and lipid levels independent of the lower intake of refined sugar. This might be explained by differences in the metabolism of carbohydrates and in the gut microbiota. The healthier phenotype was confirmed by a SI knockout mouse model, which furthermore interestingly indicated that the variant might alter food and taste preferences.
It is anticipated that the drastic increase in type 2 diabetes in Greenland can be explained at least partly by the complex interaction between lifestyle and genetics. Therefore, the aim is to investigate if metabolic and microbial differences can explain the healthier phenotype of the homozygous carriers of the SI variant than wildtype individuals amd perform a 3-day cross-over dietary intervention using assigning subjects to a traditional Greenlandic diet and a Western diet. Moreover, the aim is to assess whether their food and taste preferences are different. The study will help us to understand the complex interactions between lifestyle, behavior, genetics, the microbiota and the host metabolism.
In this human study, effects of the SI knockout variant on metabolism, dietary habits and food preferences will be quantified. The study will be unique by being the first assessing the effect of a complete loss of SI function, which it is only feasible in Arctic populations.
Differences between homozygous (HO) carriers and heterozygous (HE)/wildtype (WT) individuals are suspected to be large on a carbohydrate-rich diet and small on a traditional diet. The following hypotheses will be addressed:
HO carriers metabolize carbohydrates differently than HE+WT individuals:
HO have a lower glycemic variability on their habitual diet than WT+HE.
HO have a lower glycemic variability on a starch and sucrose rich diet than WT+HE.
HO have a glycemic variability similar to WT+HE on a traditional diet low in carbohydrates.
HO carriers have different food preferences than HE+WT individuals:
HO have a lower sweet taste preference compared to WT+HE.
HO perceive iso-intense solutions of sucrose, fructose, and glucose differently in sweet taste intensity and WT+HE will perceive them iso-intense.
HO consume less high-sugar-low-fat foods than WT+HE.
HO have similar intake and preference for high-sugar-high-fat foods as WT+HE.
HO carriers have a microbiota different from HE+WT individuals:
Diversity and abundance of starch-fermenting bacteria is higher in HO than in WT+HE and the abundance of Parabacteroides is lower.
The increase in starch-fermenting bacteria as well as fecal and circulating levels of short chain fatty acids is larger for HO than in WT+HE on a starch and sucrose rich diet.
A diet low in carbohydrates will alter the microbiota similarly for HO and WT+HE.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Traditional Inuit Diet | Active Comparator | The traditional Inuit diet will consist of local foods, being primarily of animal origin, e.g. fish, marine mammals, caribou, and lamb. The diet will be supplemented with eggs, potatoes, and berries, and/or other foods low in starch and with no sucrose content. The diet will therefore have a high content of fat and protein, a low content of carbohydrate and no content of sucrose. The participants will receive foods that will cover at least 100% of their energy requitement. Each participant will throw a dice in order to randomize the order of which the participants receive the two intervention diets. |
|
| Western Carbohydrate-Rich Diet | Experimental | The Western diet will have high amounts of grain products, e.g. bread, pasta, rice, as well as fruits and vegetables and some foods with a high sucrose content, e.g. cake and sweet snacks and/or drinks, and cereal products with added sucrose. The diet will have a low amount of meat. Hence, the diet will be high in carbohydrates, starch, and some sucrose and have a lower content of protein and fat. The participants will receive foods that will cover at least 100% of their energy requitement. Each participant will throw a dice in order to randomize the order of which the participants receive the two intervention diets. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Cross-over study | Other | Traditional Inuit Diet and Western Diet. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Glycemic variability during Western diet | Glycemic variability will be measured by mean amplitude of glycemic excursions (MAGE) during the whole study period, i.e. during both Western and Inuit diet and the wash-out period in between. | During the 3 days of intervention with Western diet. |
| Glycemic variability during Inuit diet | Glycemic variability will be measured by mean amplitude of glycemic excursions (MAGE) during the whole study period, i.e. during both Western and Inuit diet and the wash-out period in between. | During the 3 days of intervention with Inuit diet. |
| Measure | Description | Time Frame |
|---|---|---|
| Sweet Bias Score | As a food reward measure, explicit liking for foods with sweet relative to savory taste will be assessed using the Leeds Food Preference Questionnaire. A sweet bias score will be estimated, where a positive score indicates higher preference for sweet relative to savoury foods and a negative score indicates higher preference for savoury foods. | Baseline (to assess differences between genotypes, independent of the intervention) |
| Measure | Description | Time Frame |
|---|---|---|
| Body weight | Weight (kg). Measured when the participant is wearing light underwear. | Baseline (participant characteristics) |
| Height | Height (cm). Measured when the participant is not wearing shoes. |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Marit E Jørgensen, Prof. | Steno Diabetes Center Greenland | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Maniitsoq Healthcare Center | Maniitsoq | Greenland | ||||
| Pikialaarfik, Greenland Institute of Natural Resources |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 41995844 | Derived | Senftleber N, Christensen MMB, Carstensen B, Staeger FF, Frost MB, Gillum MP, Hansen T, Jorgensen ME. Dietary effect on glucose homeostasis is modulated by a loss-of-function variant in the sucrase-isomaltase gene: a randomised, dietary crossover intervention in Inuit. Diabetologia. 2026 Jul;69(7):2015-2028. doi: 10.1007/s00125-026-06723-4. Epub 2026 Apr 17. | |
| 38113483 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
A cross-over design will be applied to the intervention. Participants will be randomized to first receive either a diet high in starch and relatively high in sucrose, resembling a western diet, or a diet low in carbohydrate with many marine foods, resembling a traditional Inuit diet. There will be a wash out period of 7 days between the two diets.
Each participant will throw a dice in order to randomize the order of which the participants receive the two intervention diets.
Not provided
Not provided
The study will be blinded with respect to the genotype of the participants for everyone involved in the study except for the investigator. The dietary intervention will not be blinded.
| Fat Bias Score | As a food reward measure, explicit liking for foods with high-fat relative to low-fat content will be assessed using the Leeds Food Preference Questionnaire. A fat bias score will be estimated, where a positive score indicates higher preference for high-fat relative to low-fat foods and a negative score indicates higher preference for low-fat foods. | Baseline (to assess differences between genotypes, independent of the intervention) |
| High-fat savory preference | As a food reward measure, explicit liking for high-fat savory foods will be assessed in the Leeds Food Preference Questionnaire. The average rating from 0-100 on the visual analogue scale is calculated for all four foods within the food category. | Baseline (to assess differences between genotypes, independent of the intervention) |
| Low-fat savory preference | As a food reward measure, explicit liking for low-fat savory foods will be assessed in the Leeds Food Preference Questionnaire. The average rating from 0-100 on the visual analogue scale is calculated for all four foods within the food category. | Baseline (to assess differences between genotypes, independent of the intervention) |
| High-fat sweet preference | As a food reward measure, explicit liking for high-fat sweet foods will be assessed in the Leeds Food Preference Questionnaire. The average rating from 0-100 on the visual analogue scale is calculated for all four foods within the food category. | Baseline (to assess differences between genotypes, independent of the intervention) |
| Low-fat sweet preference | As a food reward measure, explicit liking for low-fat sweet foods will be assessed in the Leeds Food Preference Questionnaire. The average rating from 0-100 on the visual analogue scale is calculated for all four foods within the food category. | Baseline (to assess differences between genotypes, independent of the intervention) |
| Implicit wanting score: High-fat savory foods | As a food reward measure, implicit wanting for high-fat savory foods will be assessed using the Leeds Food Preference Questionnaire. The 'implicit wanting' score is calculated based on a combination of reaction time and choice or non-choice of foods in the forced choice paradigm. A positive score indicates a higher preference for this food category compared to the other food categories, and a negative score indicates a lower preference for this food category. | Baseline (to assess differences between genotypes, independent of the intervention) |
| Implicit wanting score: Low-fat savory foods | As a food reward measure, implicit wanting for low-fat savory foods will be assessed using the Leeds Food Preference Questionnaire. The 'implicit wanting' score is calculated based on a combination of reaction time and choice or non-choice of foods in the forced choice paradigm. A positive score indicates a higher preference for this food category compared to the other food categories, and a negative score indicates a lower preference for this food category. | Baseline (to assess differences between genotypes, independent of the intervention) |
| Implicit wanting score: High-fat sweet foods | As a food reward measure, implicit wanting for high-fat sweet foods will be assessed using the Leeds Food Preference Questionnaire. The 'implicit wanting' score is calculated based on a combination of reaction time and choice or non-choice of foods in the forced choice paradigm. A positive score indicates a higher preference for this food category compared to the other food categories, and a negative score indicates a lower preference for this food category. | Baseline (to assess differences between genotypes, independent of the intervention) |
| Implicit wanting score: Low-fat sweet foods | As a food reward measure, implicit wanting for low-fat sweet foods will be assessed using the Leeds Food Preference Questionnaire. The 'implicit wanting' score is calculated based on a combination of reaction time and choice or non-choice of foods in the forced choice paradigm. A positive score indicates a higher preference for this food category compared to the other food categories, and a negative score indicates a lower preference for this food category. | Baseline (to assess differences between genotypes, independent of the intervention) |
| Habitual diet | Habitual dietary intake will be assessed using a food frequency questionnaire. Macronutrient composition and content of sugar will be assessed as well as characterization of differences in food choice with respect to sweet foods and foods rich in starch. Intake will be expressed in g/day as well as E%. | Baseline (to assess differences between genotypes, independent of the intervention) |
| Intake in a snacking test meal | Using an ad libitum snacking test meal, preferences will be assessed for sweet-taste and content of sucrose and fat as well as other sweeteners than sucrose, e.g. honey. | Baseline (to assess differences between genotypes, independent of the intervention) |
| Sucrose sweetness sensitivity | Ability to taste a difference between iso-intense solutions of sucrose and fructose+glucose using a 2-alternative forced choice test | Baseline (to assess differences between genotypes, independent of the intervention) |
| Sweet liking | Hedonic rating of liking of iso-intense solutions of sucrose, fructose, glucose and fructose+glucose using a visual analogue scale (0-100 mm) | Baseline (to assess differences between genotypes, independent of the intervention) |
| Perceived intensity of sugars | Hedonic rating of perceived intensity of iso-intense solutions of sucrose, fructose, glucose and fructose+glucos using a visual analogue scale (0-100 mm) | Baseline (to assess differences between genotypes, independent of the intervention) |
| Plasma lipids | Changes in fasting plasma measures of VLDL-cholesterol, LDL-cholesterol, HDL-cholesterol, total cholesterol, remnant cholesterol, and triglycerides | The day before and the day after each dietary intervention period. |
| Serum insulin | Changes in serum insulin. Fasting sample. | The day before and the day after each dietary intervention period. |
| Plasma CRP | Changes in plasma CRP. Fasting sample. | The day before and the day after each dietary intervention period. |
| Plasma acetate | Changes in plasma acetate. Fasting sample. | The day before and the day after each dietary intervention period. |
| Plasma propionate | Changes in plasma propionate. Fasting sample. | The day before and the day after each dietary intervention period. |
| Plasma butyrate | Changes in plasma butyrate. Fasting sample. | The day before and the day after each dietary intervention period. |
| HbA1c | Fasting glycated hemoglobin | Baseline |
| Fecal acetate | Changes in fecal acetate. | Before and on the last day or on the day after each dietary intervention period. |
| Fecal propionate | Changes in fecal propionate. | Before and on the last day or on the day after each dietary intervention period. |
| Fecal butyrate | Changes in fecal butyrate. | Before and on the last day or on the day after each dietary intervention period. |
| Fecal pH | pH of fecal samples. | Before and on the last day or on the day after each dietary intervention period. |
| Changes in gut microbiota composition | Changes in gut microbiota composition between baseline and end of each dietary intervention period. Microbiota composition is measured by genome sequencing fecal samples. | Before and on the last day or on the day after each dietary intervention period. |
| Baseline gut microbiota composition | Characterization of the gut microbiota composition. Microbiota composition is measured by genome sequencing fecal samples. | Before intervention (baseline). |
| Fecal carbohydrates | Content of carbohydrates in fecal samples and changes in this during the intervention periods. | Before and on the last day or on the day after each dietary intervention period. |
| Glycemic variability during habitual diet | Glycemic variability will be measured by mean amplitude of glycemic excursions (MAGE) | Measured during 7 days of wash-out |
| Baseline (participant characteristics) |
| Hip circumference | Hip circumference (cm). Measured when the participant is wearing light underwear. | Baseline (participant characteristics) |
| Waist circumference | Waist circumference (cm). Measured when the participant is wearing light underwear. | Baseline (participant characteristics) |
| Body composition | Body fat percentage measured using a Tanita body composition analyser. | Baseline (participant characteristics) |
| Plasma lipodomics. | For future analyses | The day before and the day after each dietary intervention period. |
| Plasma metabolomics. | For future analyses | The day before and the day after each dietary intervention period. |
| Plasma proteomics. | For future analyses | The day before and the day after each dietary intervention period. |
| Fecal lipodomics | For future analyses | The day before and the day after each dietary intervention period. |
| Fecal metabolomics. | For future analyses | The day before and the day after each dietary intervention period. |
| Fecal proteomics. | For future analyses | The day before and the day after each dietary intervention period. |
| Nuussuaq |
| 3905 |
| Greenland |
| Senftleber NK, Skott Pedersen K, Schnoor Jorgensen C, Pedersen H, Bjerg Christensen MM, Kabel Madsen E, Andersen K, Jorsboe E, Gillum MP, Frost MB, Hansen T, Jorgensen ME. The effect of sucrase-isomaltase deficiency on metabolism, food intake and preferences: protocol for a dietary intervention study. Int J Circumpolar Health. 2023 Dec;82(1):2178067. doi: 10.1080/22423982.2023.2178067. Epub 2023 Feb 22. |
| ID | Term |
|---|---|
| D003924 | Diabetes Mellitus, Type 2 |
| D008659 | Metabolic Diseases |
| C538139 | Sucrase-isomaltase deficiency, congenital |
| D003920 | Diabetes Mellitus |
| D005518 | Food Preferences |
| ID | Term |
|---|---|
| D044882 | Glucose Metabolism Disorders |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |
| D005247 | Feeding Behavior |
| D001519 | Behavior |
Not provided
Not provided
| ID | Term |
|---|---|
| D018592 | Cross-Over Studies |
| ID | Term |
|---|---|
| D015340 | Epidemiologic Research Design |
| D004812 | Epidemiologic Methods |
| D008919 | Investigative Techniques |
| D017531 | Health Care Evaluation Mechanisms |
| D011787 | Quality of Health Care |
| D017530 | Health Care Quality, Access, and Evaluation |
| D011634 | Public Health |
| D004778 | Environment and Public Health |
Not provided
Not provided